One of the lead investigators, Dr Anne-Sofie Halling from the Bispebjerg Hospital at the University of Copenhagen, said: “To our knowledge, this is the first to show that non-invasively collected skin biomarkers can be used to predict the subsequent onset and severity of paediatric atopic eczema.”
